Surgical stage of treatment of hepatoblastoma in patients with ventriculoperitoneal shunt: results of two clinical case

Hepatoblastoma is considered the most common malignant tumor with a stable tendency towards increased incidence in children. Prematurity is recognized as one of the significant risk factors associated with its development. Prematurity often coexists with a wide range of comorbid conditions, particularly in cases of deep prematurity stage IV. Such children are predisposed to a significant risk of intraventricular bleeding and chronic lung conditions, including bronchoalveolar dysplasia. The incidence of intraventricular bleeding is estimated to be between 20–40 %, while bronchoalveolar dysplasia ranges from 35–80 %. In cases of hepatoblastoma in premature children with these comorbid conditions, the surgical management stage (which typically includes chemotherapy) carries additional risks. There is limited data available regarding abdominal surgery in such patients, and notably, there have been no documented examples of extensive liver resections in this population. In this article, we will discuss two clinical cases detailing the surgical management of children with prematurity.

1. Linabery A.M., Ross J.A. Trends in childhood cancer incidence in the U.S. (1992–2004). Cancer. 2008;112(2):416–32. doi: 10.1002/cncr.23169.

2. Howlader N., Noone A.M., Krapcho M., Neyman N., Aminou R., Waldron W., Altekruse S.F., Kosary C.L., Ruhl J., Tatalovich Z., Cho H., Mariotto A., Eisner M.P., Lewis D.R., Chen H.S., Feuer E.J., Cronin K.A., Edwards B.K. SEER Cancer Statistics Review, 1975– 2008. National Cancer Institute, Bethesda, MD. Based on November 2010 SEER Data Submission. Posted to SEER Web Site, 2011 [Electronic resource]. URL: https://seer.cancer.gov/csr/1975_2008/.

3. Ikeda H., Matsuyama S., Tanimura M. Association between hepatoblastoma and very low birth weight: A trend or a chance? J Pediatr. 1997;130(4):557–60. doi: 10.1016/S0022-3476(97)70239-7.

4. Spector L.G., Johnson K.J., Soler J.T., Puumala S.E. Perinatal risk factors for hepatoblastoma. Br J Cancer. 2008;98(9):1570–3. doi: 10.1038/sj.bjc.6604335.

5. Paquette K., Coltin H., Boivin A., Amre D., Nuyt A.M., Luu T.M. Cancer risk in children and young adults born preterm: a systematic review and meta-analysis. PLoS One 2019;14(1):1–15. doi: 10.1371/journal.pone.0210366.

6. Intraventricular hemorrhages, posthemorrhagic hydrocephalus in newborns. Principles of medical care. Methodological recommendations of the Russian Association of Perinatal Medicine Specialists together with the Association of Children’s Neurosurgeons of Russia. Edited by Volodin N.N., Gorelyshev S.K., Popov V.E. M., 2014. (In Russ.)

7. Palchik A.B., Fedorova L.A., Ponyatishin A.E. Intraventricular hemorrhages in newborns. St. Petersburg: SPbGPMU, 2019. 50 p. (In Russ.)

8. Deger J., Goethe E.A., LoPresti M.A., Lam S. Intraventricular Hemorrhage in Premature Infants: A Historical Review. World Neurosurg. 2021;153:21–5. doi: 10.1016/j.wneu.2021.06.043.

9. Baranov A.A., Namazova-Baranova L.S., Volodin N.N., Davydova I.V., Ovsyannikov D.Yu., Ivanov D.O., Boytsova E.V., Yatsyk G.V., Antonov A.G., Ionov O.V., Ryndin A.Yu., Grebennikov V.A.,Soldatova I.G., Chubarova A.I. Management of children with bronchopulmonary dysplasia. Pediatricheskaya farmakologiya = Pediatric Pharmacology. 2016;13(4):319–33. doi: 10.15690/pf.v13i4.1603. (In Russ.)

10. Ovsyannikova D.Yu., Geppe N.A., Malakhova A.B., Degtyareva D.N. Bronchopulmonary dysplasia. Monograph. Russian Respiratory Society, Pediatric Respiratory Society, Russian Society of Neonatologists, Federation of Pediatricians of the CIS Countries, 2020. (In Russ.)

11. Jensen E.A., Edwards E.M., Greenberg L.T., Soll R.F., Ehret D.E.Y., Horbar J.D. Severity of bronchopulmonary dysplasia among very preterm infants in the United States. Pediatrics. 2021;148(1):1–8. doi: 10.1542/peds.2020-030007.

12. Spector L.G., Birch J. The epidemiology of hepatoblastoma. Pediatr Blood Cancer. 2012;59(5):776–9. doi: 10.1002/pbc.24215.

13. Al-Holou W.N., Wilson T.J., Ali Z.S., Brennan R.P., Bridges K.J., Guivatchian T., Habboub G., Krishnaney A.A., Lanzino G., Snyder K.A., Flanders T.M., Than K.D., Pandey A.S. Gastrostomy tube placement increases the risk of ventriculoperitoneal shunt infection: A multiinstitutional study. J Neurosurg. 2018:1–6. doi: 10.3171/2018.5.JNS18506.

14. Ong A.W., Lapham D.A., Psarros S. Infectious complications in patients with ventriculoperitoneal shunts after intra-abdominal procedures. Am J Surg. 2016;82(7):E146–9. doi: 10.1177/000313481608200707.

15. Li G., Dutta S. Perioperative management of ventriculoperitoneal shunts during abdominal surgery. Surg Neurol. 2008;70(5):492–5. doi: 10.1016/j.surneu.2007.08.050.

16. Roeder B.E., Said A., Reichelderfer M., Gopal D.V. Placement of gastrostomy tubes in patients with ventriculoperitoneal shunts does not result in increased incidence of shunt infection or decreased survival. Dig Dis Sci. 2007;52(2):518–22. doi: 10.1007/s10620-006-9311-1.

17. Cools M.J., Vance E.H., Bonfi eld C.M. Ventriculoperitoneal shunt management in children undergoing liver transplantation. Child’s Nerv Syst. 2022;38(7):1393–5. doi: 10.1007/s00381-021-05411-5.

18. Speicher P.J., Nussbaum D.P., Scarborough J.E., Zani S., White R.R., Blazer D.G. 3rd, Mantyh C.R., Tyler D.S., Clary B.M. Wound classifi cation reporting in HPB surgery: Can a single word change public perception of institutional performance? HPB (Oxford). 2014;16(12):1068–73. doi: 10.1111/hpb.12275.

19. Faybush E., Mulligan D.C., Birch B.D., Sirven J.I., Balan V. Liver transplant in a patient with a ventriculoperitoneal shunt. Liver Transplant. 2005;11(4):467–8. doi: 10.1002/lt.20371.